|
Study of Aripiprazole in the Treatment of Patients with Acute Symptoms in Bipolar Disorder Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on Study of Aripiprazole in the Treatment of Patients with Acute Symptoms in Bipolar Disorder conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Study of Aripiprazole in the Treatment of Patients with Acute Symptoms in Bipolar Disorder Clinical research trials and Study of Aripiprazole in the Treatment of Patients with Acute Symptoms in Bipolar Disorder healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including Study of Aripiprazole in the Treatment of Patients with Acute Symptoms in Bipolar Disorder. Study of Aripiprazole in the Treatment of Patients with Acute Symptoms in Bipolar Disorder Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a Study of Aripiprazole in the Treatment of Patients with Acute Symptoms in Bipolar Disorder clinical trial. Participants typically obtain the most effective healthcare available for their Study of Aripiprazole in the Treatment of Patients with Acute Symptoms in Bipolar Disorder condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Study of Aripiprazole in the Treatment of Patients with Acute Symptoms in Bipolar Disorder  Study of Aripiprazole in the Treatment of Patients with Acute Symptoms in Bipolar Disorder
Study of Aripiprazole in the Treatment of Patients with Acute Symptoms in Bipolar Disorder
For Condition: Bipolar Disorder
Status: No longer recruiting
Sponsor(s): Bristol-Myers Squibb ,
Synopsis: The purpose of this study is to learn if aripiprazole is effective for the treatment of patients with acute symptoms of Bipolar disorder.
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: Patients with acute symptoms of Bipolar Disorder
Total Enrollment:
Location and Contact Information:
Local Institution
Indianapolis, Indiana,
United States
Local Institution
Falls Church, Virginia,
United States
Local Institution
Newton Center, Massachusetts,
United States
Local Institution
Austin, Texas,
United States
Local Institution
Cincinnati, Ohio,
United States
Local Institution
San Diego, California,
United States
Local Institution
Miami, Florida,
United States
Local Institution
New Baltimore, Michigan,
United States
Local Institution
San Diego, California,
United States
Local Institution
Medina, Ohio,
United States
Local Institution
Washington D.C., District of Columbia,
United States
Local Institution
Tuscallosa, Alabama,
United States
Local Institution
Riverside, California,
United States
Local Institution
Stanford, California,
United States
Local Institution
Houston, Texas,
United States
Local Institution
Chicago, Illinois,
United States
Local Institution
Louisville, Kentucky,
United States
Local Institution
Honolulu, Hawaii,
United States
Local Institution
Lawrence, New York,
United States
Local Institution
Philadelphia, Pennsylvania,
United States
Local Institution
Beachwood, California,
United States
Local Institution
San Clemente, California,
United States
Local Institution
Little Rock, Arizona,
United States
Local Institution
Houston, Texas,
United States
Local Institution
Winter Park, Florida,
United States
Local Institution
Butner, North Carolina,
United States
Local Institution
Belmont, Massachusetts,
United States
Local Institution
Bellevue, Washington,
United States
Local Institution
Chula Vista, California,
United States
Local Institution
Cincinnati, Ohio,
United States
Additional Information:
Study ID Numbers: CN138-074;
Study Start Date:
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00036101
Other Bipolar Disorder Studies:
1. Bipolar Study
2. Seroquel plus Mood Stabilizer Compared to Placebo plus Mood Stabilizer in the Maintenance of Bipolar I Disorder
3. A study to evaluate the safety and effectiveness of topiramate compared to placebo in the treatment of Bipolar I Disorder.
4. A Study of the Safety and Efficacy of Topiramate in the Treatment of Patients with Bipolar I Disorder
5. Effects of Sex Hormones on Circadian Rhythm in Men and Women
Related Studies:
Other Bipolar Disorder Clinical Trials
Other Kentucky Clinical Trials
Other Louisville Clinical Trials
Study of Aripiprazole in the Treatment of Patients with Acute Symptoms in Bipolar Disorder
|
|
|
|
|
|
|
|
